Marshall Wace’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $437K | Sell |
86,312
-247,300
| -74% | -$1.25M | ﹤0.01% | 2061 |
|
|
2025
Q1 | $1.76M | Buy |
+333,612
| New | +$1.76M | ﹤0.01% | 1424 |
|
|
2024
Q2 | – | Sell |
-391,518
| Closed | -$3.9M | – | 2641 |
|
|
2024
Q1 | $3.9M | Buy |
+391,518
| New | +$3.9M | 0.01% | 965 |
|
|
2023
Q2 | – | Sell |
-514,137
| Closed | -$3.43M | – | 2451 |
|
|
2023
Q1 | $3.43M | Buy |
+514,137
| New | +$3.43M | 0.01% | 968 |
|
|
2022
Q3 | – | Sell |
-106,786
| Closed | -$869K | – | 3009 |
|
|
2022
Q2 | $869K | Buy |
+106,786
| New | +$869K | ﹤0.01% | 1932 |
|